Home > Products > CD3 & CD33 > Recombinant Anti-CD3 VHH x Anti-CD33 VHH BispecificAntibody (Bi-sdAb)

Recombinant Anti-CD3 VHH x Anti-CD33 VHH BispecificAntibody (Bi-sdAb)  (CAT#: BIVHH-014)

Recombinant Anti-CD3 x Anti-CD33 Bispecific Antibody (Bi-sdAb) is designed to be expressed as a VHH from anti-CD3 antibody variable domains fused with a VHH from an anti-CD33 antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer therapy.
Datasheet INQUIRY

Specifications

Targets
CD3 & CD33
Type
Bi-sdAb
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Acute myeloid leukemia (AML); Ulcerative Colitis (UC); Myelodysplastic syndromes (MDS); Gastric cancer

Targets

Target 1
CD3
Gene ID
UniProt ID
Alternative Names
CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3
Target 2
CD33
Gene ID
UniProt ID
Alternative Names
CD33; CD33 molecule; Cluster of differentiation 33; p67; SIGLEC3; SIGLEC-3; myeloid cell surface antigen CD33; gp67; CD33 antigen (gp67); sialic acid binding Ig-like lectin 3; sialic acid-binding Ig-like lectin 3
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

Related products of "CD3 & CD33"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD3 VHH x Anti-CD33 VHH BispecificAntibody (Bi-sdAb) (BIVHH-014). Click the button below to contact us or submit your feedback about this product.